As of 2025-10-31, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (33.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -1023.3%.
The range of the Relative Valuation is (32.01) - (34.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 19.5x | 18.2x |
| Forward P/E multiples | 18.1x - 22.4x | 19.9x |
| Fair Price | (32.01) - (34.42) | (33.70) |
| Upside | -977.1% - -1043.0% | -1023.3% |
| Date | P/E |